Ad
IGMS Quote Trading Chart IGM Biosciences Inc.
home / stock / igms / igms quote
Quote | IGM Biosciences Inc. (NASDAQ:IGMS)
| Last: | $14.6953 |
|---|---|
| Change Percent: | 2.05% |
| Open: | $14.19 |
| Close: | $14.40 |
| High: | $14.86 |
| Low: | $13.78 |
| Volume: | 104,455 |
| Last Trade Date Time: | 10/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
IGMS Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $14.6953 | $14.19 | $14.4 | $14.86 | $13.78 | 104,455 | 10-03-2024 |
| $14.4 | $14.52 | $14.4 | $14.94 | $13.25 | 389,373 | 10-02-2024 |
| $14.5 | $11.43 | $14.5 | $15.25 | $11.3 | 1,549,830 | 10-01-2024 |
| $16.54 | $16.7 | $16.54 | $18.38 | $15.5 | 765,574 | 09-30-2024 |
| $17 | $16.33 | $17 | $18.01 | $16.0301 | 360,475 | 09-27-2024 |
| $15.86 | $16.61 | $15.86 | $17.05 | $15.27 | 277,059 | 09-26-2024 |
| $16.41 | $17.06 | $16.41 | $18.37 | $16.09 | 302,782 | 09-25-2024 |
| $16.89 | $16.36 | $16.89 | $17.55 | $15.6864 | 410,336 | 09-24-2024 |
| $15.99 | $16.37 | $15.99 | $16.39 | $15.57 | 395,978 | 09-23-2024 |
| $16.16 | $17.3 | $16.16 | $17.3 | $15.7 | 597,983 | 09-20-2024 |
| $17.23 | $17.3 | $17.23 | $18.69 | $16.41 | 380,288 | 09-19-2024 |
| $16.65 | $17.77 | $16.65 | $18.3235 | $15.24 | 464,773 | 09-18-2024 |
| $17.68 | $15.71 | $17.68 | $22.5 | $14.9419 | 2,273,975 | 09-17-2024 |
| $15.84 | $12.4 | $15.84 | $15.88 | $12.35 | 521,051 | 09-16-2024 |
| $12.3 | $11.44 | $12.3 | $12.5 | $11.1801 | 152,567 | 09-13-2024 |
| $11.39 | $11.52 | $11.39 | $11.865 | $11.1048 | 155,108 | 09-12-2024 |
| $11.74 | $11.28 | $11.74 | $11.83 | $10.96 | 132,934 | 09-11-2024 |
| $11.27 | $10.36 | $11.27 | $11.31 | $10.36 | 206,973 | 09-10-2024 |
| $10.27 | $9.41 | $10.27 | $10.47 | $9.41 | 149,942 | 09-09-2024 |
| $9.31 | $10.21 | $9.31 | $10.4 | $9.18 | 119,642 | 09-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
2024-10-01 07:59:56 ET Asthika Goonewardene from Truist Financial issued a price target of $12.00 for IGMS on 2024-10-01 06:52:00. The adjusted price target was set to $12.00. At the time of the announcement, IGMS was trading at $16.54. The overall price target consensus...
-
– Company to prioritize its pipeline of T cell engagers in autoimmune diseases, including ongoing clinical development of imvotamab in rheumatoid arthritis and systemic lupus erythematosus – – Mary Beth Harler, M.D., appointed as Chief Executive Officer and to Board o...
-
MOUNTAIN VIEW, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, and Mary Beth Harler, M.D., Head, Research & ...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the development of the new next generation AABB Wallet App is nearing completion. The AABB Wallet development team, led by the Koinfold Cr...